OBJECTIVE: The pathogenesis of multiple organ dysfunction syndrome (MODS) in septic shock is mainly caused by maldistribution of tissue perfusion and the amplification of inflammatory responses, which may be modulated by beta(2)-adrenoceptor agonists. We evaluated and compared effects of terbutaline on MODS in a cecal ligation and puncture (CLP) model of sepsis. DESIGN AND SETTING: Prospective controlled animal study in a university laboratory. METHODS: Male adult Wistar rats received CLP or sham operation followed by the administration of saline or terbutaline (0.3 mg/kg i.v. at 3 and 9 h after CLP). MEASUREMENTS AND RESULTS: At 0, 9 and 18 h after CLP, the changes of hemodynamics, organ function indexes, as well as the plasma interleukin-1beta (IL-1beta) and nitrite/nitrate levels were examined. At 18 h after CLP, animals were killed and their lungs, livers and kidneys were immediately excised to analyze superoxide anion (O(2) (-)) levels and inducible nitric oxide synthase (iNOS) expression. These organs were also evaluated by pathological study. Terbutaline significantly (1) prevented delayed hypotension and reduced hepatic and renal dysfunction, (2) diminished plasma IL-1beta and nitrite/nitrate, lung iNOS expression, tissue O(2) (-) level and the infiltration of neutrophils in the lung and the liver, and (3) improved the 18-h survival rate. CONCLUSIONS: Terbutaline may be developed as an alternative treatment for severe sepsis-induced MODS. The protective effect of terbutaline seems to be through inhibition of proinflammatory mediators and attenuation of oxidant production.
OBJECTIVE: The pathogenesis of multiple organ dysfunction syndrome (MODS) in septic shock is mainly caused by maldistribution of tissue perfusion and the amplification of inflammatory responses, which may be modulated by beta(2)-adrenoceptor agonists. We evaluated and compared effects of terbutaline on MODS in a cecal ligation and puncture (CLP) model of sepsis. DESIGN AND SETTING: Prospective controlled animal study in a university laboratory. METHODS: Male adult Wistar rats received CLP or sham operation followed by the administration of saline or terbutaline (0.3 mg/kg i.v. at 3 and 9 h after CLP). MEASUREMENTS AND RESULTS: At 0, 9 and 18 h after CLP, the changes of hemodynamics, organ function indexes, as well as the plasma interleukin-1beta (IL-1beta) and nitrite/nitrate levels were examined. At 18 h after CLP, animals were killed and their lungs, livers and kidneys were immediately excised to analyze superoxide anion (O(2) (-)) levels and inducible nitric oxide synthase (iNOS) expression. These organs were also evaluated by pathological study. Terbutaline significantly (1) prevented delayed hypotension and reduced hepatic and renal dysfunction, (2) diminished plasma IL-1beta and nitrite/nitrate, lung iNOS expression, tissue O(2) (-) level and the infiltration of neutrophils in the lung and the liver, and (3) improved the 18-h survival rate. CONCLUSIONS:Terbutaline may be developed as an alternative treatment for severe sepsis-induced MODS. The protective effect of terbutaline seems to be through inhibition of proinflammatory mediators and attenuation of oxidant production.
Authors: K Kuroki; H K Takahashi; H Iwagaki; T Murakami; M Kuinose; S Hamanaka; K Minami; M Nishibori; N Tanaka; K Tanemoto Journal: J Int Med Res Date: 2004 Sep-Oct Impact factor: 1.671
Authors: C A Izeboud; K H N Hoebe; A F Grootendorst; S M Nijmeijer; A S van Miert; R R Witkamp; R J T Rodenburg Journal: Inflamm Res Date: 2004-02-16 Impact factor: 4.575
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2011-01-04 Impact factor: 17.440
Authors: Laena Pernomian; Alejandro F Prado; Bruno R Silva; Aline Azevedo; Lucas C Pinheiro; José E Tanus-Santos; Lusiane M Bendhack Journal: Front Physiol Date: 2016-06-23 Impact factor: 4.566
Authors: Mansoor Nawaz Bangash; Tom E F Abbott; Nimesh S A Patel; Charles Johnston Hinds; Christoph Thiemermann; Rupert Mark Pearse Journal: Front Immunol Date: 2020-05-21 Impact factor: 7.561
Authors: Yan Ding; Pan Liu; Zhi-Lin Chen; Shao-Jun Zhang; You-Qin Wang; Xin Cai; Lei Luo; Xuan Zhou; Lei Zhao Journal: Front Pharmacol Date: 2018-08-22 Impact factor: 5.810